CN106456666A - 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法 - Google Patents
使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法 Download PDFInfo
- Publication number
- CN106456666A CN106456666A CN201580010494.4A CN201580010494A CN106456666A CN 106456666 A CN106456666 A CN 106456666A CN 201580010494 A CN201580010494 A CN 201580010494A CN 106456666 A CN106456666 A CN 106456666A
- Authority
- CN
- China
- Prior art keywords
- gas
- dosage
- child
- nitric oxide
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Abstract
Description
变量 | 安慰剂 | 一氧化氮5ppm |
最初插管、在PICU中和在补充O2时的天数 | ||
最初插管的天数-平均值(SD) | 15.8(11.2) | 13.6(6.8) |
在PICU中的天数-平均值(SD) | 25.6(15.4) | 17.8(8.3) |
补充O2时的天数-平均值(SD) | 18.8(15.0) | 19.6(13.4) |
放气评估 | ||
N | 29 | 26 |
存活,n(%) | 21(72.4%) | 23(88.5%) |
死亡(与肺部病状有关的死因),n(%) | 1(3.4%) | 0(0) |
在第28天接受补充的O2,n(%) | 8(27:6%) | 11(42.3%) |
第28天插管,n(%) | 5(17.2%) | 2(7.7%) |
在治疗期间任何时间的HFOV,n(%) | 18(62.1%) | 11(42.3%) |
在治疗期间任何时间的ECMO,n(%) | 7(24.1%) | 0(0) |
临床败血症,n(%) | 4(13.8%) | 4(15.4%) |
VAP,n(%) | 1(3.4%) | 5(19.2%) |
气胸,n(%) | 10(34.5%) | 3(11.5%) |
治疗持续时间 | 安慰剂 | 一氧化氮5ppm |
N天 | 28 | 25 |
平均值(SD) | 13.2(8.8) | 12.7(7.0) |
中值 | 10.7 | 12.7 |
范围 | (0.4,28.1) | (2.8,29.0) |
Claims (21)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461925925P | 2014-01-10 | 2014-01-10 | |
US61/925,925 | 2014-01-10 | ||
US14/593,085 | 2015-01-09 | ||
US14/593,085 US9381212B2 (en) | 2014-01-10 | 2015-01-09 | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
PCT/US2015/010839 WO2015106115A1 (en) | 2014-01-10 | 2015-01-09 | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106456666A true CN106456666A (zh) | 2017-02-22 |
Family
ID=53520405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580010494.4A Pending CN106456666A (zh) | 2014-01-10 | 2015-01-09 | 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法 |
Country Status (6)
Country | Link |
---|---|
US (3) | US9381212B2 (zh) |
JP (2) | JP2017503801A (zh) |
CN (1) | CN106456666A (zh) |
AU (3) | AU2015204616B2 (zh) |
CA (1) | CA2936490C (zh) |
WO (1) | WO2015106115A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111135406A (zh) * | 2020-01-10 | 2020-05-12 | 宁波戴维医疗器械股份有限公司 | 一种高频呼吸机及其通气控制方法 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2936490C (en) * | 2014-01-10 | 2022-10-04 | Ino Therapeutics Llc | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
CA3054656A1 (en) | 2017-02-27 | 2018-08-30 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
CN113456966A (zh) | 2017-02-27 | 2021-10-01 | 第三极股份有限公司 | 用于移动生成一氧化氮的系统和方法 |
MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
EP3675719A4 (en) * | 2017-08-30 | 2021-07-14 | Bellerophon Pulse Technologies LLC | USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISORDER |
JP2022532654A (ja) | 2019-05-15 | 2022-07-15 | サード ポール,インコーポレイテッド | 一酸化窒素を生成するシステム及び方法 |
US11045620B2 (en) | 2019-05-15 | 2021-06-29 | Third Pole, Inc. | Electrodes for nitric oxide generation |
CN115151183A (zh) | 2020-01-11 | 2022-10-04 | 第三极股份有限公司 | 具有湿度控制的用于一氧化氮生成的系统和方法 |
AU2021275224A1 (en) * | 2020-05-21 | 2022-10-13 | EyePoint Pharmaceuticals, Inc. | Methods of treating acute respiratory distress syndrome with activators of Tie-2 |
WO2021258025A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
FR3127408A1 (fr) | 2021-09-29 | 2023-03-31 | Inosystems | Chariot hospitalier de transport de bouteille de gaz, notamment de NO médical |
FR3131538A1 (fr) | 2022-01-05 | 2023-07-07 | Inosystems | Dispositif de délivrance de NO avec système de dosage d’urgence |
EP4209243A1 (fr) | 2022-01-05 | 2023-07-12 | Inosystems | Dispositif de délivrance de no avec système de dosage d'urgence |
FR3137841A1 (fr) | 2022-07-18 | 2024-01-19 | Inosystems | Dispositif de délivrance de NO avec système de dosage d’urgence |
FR3132025A1 (fr) | 2022-01-24 | 2023-07-28 | Inosystems | Cartouche de stockage d’un mélange NO/azote et installation de fourniture de gaz associée |
FR3138773A1 (fr) | 2022-08-11 | 2024-02-16 | Inosystems | Installation de fourniture de gaz comprenant un ventilateur médical et un dispositif de délivrance de NO avec un système de dosage d’urgence |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5570683A (en) | 1990-12-05 | 1996-11-05 | The General Hospital Corporation | Methods and devices for treating pulmonary vasoconstriction and asthma |
US5558083A (en) | 1993-11-22 | 1996-09-24 | Ohmeda Inc. | Nitric oxide delivery system |
US6063407A (en) | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US5732693A (en) | 1996-10-02 | 1998-03-31 | Ohmeda Inc. | Pause control of nitric oxide therapy |
US5752504A (en) | 1996-12-13 | 1998-05-19 | Ohmeda Inc. | System for monitoring therapy during calibration |
US6164276A (en) * | 1997-05-16 | 2000-12-26 | Datex-Ohmeda, Inc. | Accurate dose nitric oxide pulse delivery device with monitoring and alarms |
US6125846A (en) | 1997-05-16 | 2000-10-03 | Datex-Ohmeda, Inc. | Purge system for nitric oxide administration apparatus |
US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
US6581599B1 (en) * | 1999-11-24 | 2003-06-24 | Sensormedics Corporation | Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients |
US7523752B2 (en) * | 2005-09-21 | 2009-04-28 | Ino Therapeutics, Llc | System and method of administering a pharmaceutical gas to a patient |
TWI474824B (zh) * | 2006-11-07 | 2015-03-01 | Gen Hospital Corp | 血管活性氧載劑所引發之血管收縮之減輕 |
JP2011000865A (ja) | 2009-06-22 | 2011-01-06 | Dainippon Printing Co Ltd | 保護層転写シート |
JP2011010865A (ja) | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
NO2661300T3 (zh) | 2011-01-06 | 2018-03-03 | ||
CA2936490C (en) * | 2014-01-10 | 2022-10-04 | Ino Therapeutics Llc | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
-
2015
- 2015-01-09 CA CA2936490A patent/CA2936490C/en active Active
- 2015-01-09 CN CN201580010494.4A patent/CN106456666A/zh active Pending
- 2015-01-09 AU AU2015204616A patent/AU2015204616B2/en active Active
- 2015-01-09 JP JP2016544840A patent/JP2017503801A/ja active Pending
- 2015-01-09 WO PCT/US2015/010839 patent/WO2015106115A1/en active Application Filing
- 2015-01-09 US US14/593,085 patent/US9381212B2/en active Active
-
2016
- 2016-06-01 US US15/170,130 patent/US10201564B2/en active Active
-
2018
- 2018-12-12 US US16/217,981 patent/US10391120B2/en active Active
-
2019
- 2019-08-08 JP JP2019146708A patent/JP2020002144A/ja active Pending
-
2020
- 2020-04-05 AU AU2020202392A patent/AU2020202392B2/en active Active
-
2022
- 2022-02-17 AU AU2022201053A patent/AU2022201053B2/en active Active
Non-Patent Citations (3)
Title |
---|
ABMAN S. H.,ET AL.: "Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure", 《THE JOURNAL OF PEDIATRICS》 * |
REAM R. S.,ET AL.: ""Low-dose inhaled nitric oxide improves the oxygenation and ventilation of infants and children with acute, hypoxemic respiratory failure"", 《CRITICAL CARE MEDICINE》 * |
TANG S. F.,ET AL.: ""Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome"", 《ARCHIVES OF DISEASE IN CHILDHOOD》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111135406A (zh) * | 2020-01-10 | 2020-05-12 | 宁波戴维医疗器械股份有限公司 | 一种高频呼吸机及其通气控制方法 |
CN111135406B (zh) * | 2020-01-10 | 2023-08-08 | 宁波戴维医疗器械股份有限公司 | 一种高频呼吸机 |
Also Published As
Publication number | Publication date |
---|---|
AU2015204616B2 (en) | 2020-04-02 |
AU2020202392A1 (en) | 2020-05-07 |
US9381212B2 (en) | 2016-07-05 |
CA2936490C (en) | 2022-10-04 |
JP2017503801A (ja) | 2017-02-02 |
AU2022201053B2 (en) | 2023-04-13 |
AU2020202392B2 (en) | 2021-12-02 |
US10391120B2 (en) | 2019-08-27 |
US20150196587A1 (en) | 2015-07-16 |
AU2015204616A1 (en) | 2016-07-21 |
AU2022201053A1 (en) | 2022-04-07 |
US20160271169A1 (en) | 2016-09-22 |
US20190183926A1 (en) | 2019-06-20 |
WO2015106115A1 (en) | 2015-07-16 |
CA2936490A1 (en) | 2015-07-16 |
JP2020002144A (ja) | 2020-01-09 |
US10201564B2 (en) | 2019-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2022201053B2 (en) | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children | |
DE69428351T3 (de) | Systemische effekte der inhalation von stickstoffoxid | |
Guervilly et al. | Prone positioning during veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adults | |
Rialp et al. | Short-term effects of inhaled nitric oxide and prone position in pulmonary and extrapulmonary acute respiratory distress syndrome | |
Diniz et al. | Effects of dexmedetomidine on pulse pressure variation changes induced by hemorrhage followed by volume replacement in isoflurane‐anesthetized dogs | |
Kissoon et al. | Ventilation strategies and adjunctive therapy in severe lung disease | |
Kabak et al. | Feasibility of non-rebreather masks and nasal cannula as a substitute for high flow nasal oxygen in patients with severe COVID-19 infection | |
Dougherty et al. | Extracorporeal membrane oxygenation in severe acute eosinophilic pneumonia | |
Brown et al. | Initiation of inhaled nitric oxide by an air transport team in adult coronavirus disease 2019 respiratory failure | |
Napolitano et al. | Tolerability and efficacy of two doses of aerosolized albuterol in ventilated infants with BPD: a randomized controlled crossover trial | |
US20230033881A1 (en) | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children | |
Adams et al. | Acute Respiratory Distress Syndrome | |
Keykha et al. | Comparison of success rate of weaning from mechanical ventilation using Burn’s Wean Assessment Program and routine method | |
Nieto et al. | Case Report: Prone Positioning and Nasal High Flow Oxygen Therapy-An Alternative Strategy to Invasive and Non-Invasive Ventilation in a Case of Severe Acute Respiratory Distress Syndrome | |
Richard et al. | Pressure versus volume assist-control ventilation in Acute Respiratory Distress Syndrome: a randomised clinical trial. | |
Napolitano et al. | Tolerability and Efficacy of Two Doses of Aerosolized Albuterol in Ventilated Infants with BPD | |
Gianni et al. | Ideation and Assessment of a Novel Nitric Oxide Delivery System for Spontaneously Breathing Subjects | |
Yilmaz et al. | Anesthetic management for cesarean delivery in a COVID-19-infected pregnant woman with renal transplant | |
Ologun et al. | Severe acute respiratory distress syndrome after laparoscopic appendectomy in a young adult | |
Kandasamy et al. | Lung Disease and Ventilator Strategies in Necrotizing Enterocolitis | |
Park et al. | A case of prolonged extracorporeal membrane oxygenation support for severe acute respiratory distress syndrome: a case report | |
Matsushita et al. | Effect of high-flow nasal cannula therapy on post-extubation hemodynamics after the Fontan procedure: A retrospective study | |
Johnson et al. | Pilot Study Comparing Closed Versus Open Tracheal Suctioning in Postoperative Neonates and Infants With Complex Congenital Heart Disease | |
CN117205416A (zh) | 一种喉罩置入时丙泊酚麻醉诱导剂量确定方法及系统 | |
Wiedmar et al. | 211: GASTRIC ACID SUPPRESSION THERAPY AS A RISK FACTOR FOR CLOSTRIDIUM DIFFICILE IN TRAUMA PATIENTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200604 Address after: Pennsylvania, USA Applicant after: Sierra AUX Address before: New jersey, USA Applicant before: INO Therapeutics LLC Effective date of registration: 20200604 Address after: Ai Erlandubailin Applicant after: Mallinckrodt intellectual property Address before: Ai Erlandubailin Applicant before: Mallinckrodt pharmaceutical intellectual property transactions DAC Effective date of registration: 20200604 Address after: Ai Erlandubailin Applicant after: Mallinckrodt pharmaceutical intellectual property transactions DAC Address before: Missouri, USA Applicant before: Mallinckrodt emergency care fund Co. Effective date of registration: 20200604 Address after: Missouri, USA Applicant after: Mallinckrodt emergency care fund Co. Address before: Pennsylvania, USA Applicant before: Sierra AUX Effective date of registration: 20200604 Address after: Ai Erlandubailin Applicant after: Mallinckrodt Hospital Products IP Ltd. Address before: Ai Erlandubailin Applicant before: Mallinckrodt intellectual property |